Investigating ulinastatin for reducing stroke risk after brain tumor surgery
Treatments studied
Part of Brain & nervous system, Cancer, Heart & circulation clinical trials.
This study tests whether giving a drug called ulinastatin during brain tumor surgery can lower the chances of having a stroke shortly after the operation. It may help patients recover with fewer complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have surgery to remove a brain tumor above the tentorium (the part of the brain that covers the upper area).
- You must be in generally good health, as classified by standard anesthesiology guidelines (ASA I-III).
- You must not have severe liver or kidney problems.
- You must not have severe bleeding disorders.
- You must not have significant pre-existing brain damage, such as severe memory loss or an inability to communicate, that would make it hard to participate.
- You must not be pregnant or breastfeeding, and you cannot join another trial at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different blood pressure management strategies during abdominal tumor surgery to see which one better protects cognitive function (thinking, memory, and clarity). It is for patients who have multiple stroke risk factors and are undergoing a lengthy surgery.
This study tests whether the drug cilostazol, when added to your usual aspirin or clopidogrel, can help prevent another stroke. It is being done in Africa and may be a good option if you've recently had a stroke or mini-stroke and want to lower your risk of another one.
This study looks at whether giving medications to prevent stomach ulcers after a stroke procedure (thrombectomy) affects recovery and outcomes. It may help understand the best care for people who have had a severe stroke.
This trial tests if a medicine called cilostazol can reduce the risk of a delayed shortage of blood in the brain after having a bleeding aneurysm treated. It aims to improve recovery by preventing a common complication called delayed cerebral ischemia.
This trial studies whether a special form of ultrasound through the skull can improve recovery after a spontaneous brain bleed that requires minimally invasive surgery. It may help by targeting the damaged brain tissue after evacuation, and the study will follow participants for up to a year.
This trial tests whether a drug called urinary kallidinogenase can help people who have had a stroke caused by a blocked artery in the brain. The drug is given within 48 hours of the stroke, and the study hopes to see if it improves recovery and reduces disability.
Hear when a new Brain Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.